PLAU and cervical cancer: Although the ScFvM61B9 intrabody did not affect either MMP-2 or MMP-9 activities in the cervical cancer HeLa cell line, it suppressed urokinase-type plasminogen activator (uPA) and inhibited HeLa cell metastasis28,31.